IBSP and metabolic disease: Furthermore, the decreased F/B ratio, which was reported to be associated with the improvement of metabolic disorder (Turnbaugh et al., 2006), was observed in the gut microbiota of BSP-1a and BSP-U100 polysaccharides treated group.